Bioxodes raises €2.7 million from existing investors in Series A extensionInterim data from BIRCH intracerebral hemorrhage (ICH) Phase 2a trial in Q1 2025Recruitment of up to 16 additional patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback